Suit Over Dating Pharma Execs' Exchange of Trade Secrets Heats Up in Discovery
The dispute between generic drugmakers Apotex and Teva stemming from a former Teva executive's alleged disclosure of trade secrets to an Apotex CEO while the two were dating is heating up, with the parties now sparring over the speed of discovery.
August 15, 2017 at 01:51 PM
3 minute read
The dispute between generic drugmakers Apotex and Teva stemming from a former Teva executive's alleged disclosure of trade secrets to an Apotex CEO while the two were dating is heating up, with the parties now sparring over the speed of discovery.
Shortly after Teva filed its lawsuit, which alleged its former senior director of regulatory affairs gave confidential information to Apotex CEO Jeremy Desai, Teva asked the U.S. District Court for the Eastern District of Pennsylvania to expedite discovery to determine the full extent of the information that was shared.
Apotex, however, pushed back Monday, arguing that Teva had been aware of the situation for more than a year before it filed the case.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250